Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dash.fi Launches Finance Platform That Audits Ad, Shipping, and AI Spend
-
Kaltura Named a Leader in Virtual Event Management Platforms, Q2 2026 Evaluation by Independent Research Firm
-
Apollo to Announce Second Quarter 2026 Financial Results on August 4, 2026
-
Byrna Technologies to Report Fiscal Second Quarter 2026 Financial Results on Thursday, July 9, 2026 at 9:00 a.m. ET
-
hyperexponential Powers Allianz Commercial's Global Pricing and Underwriting Transformation
-
CredFin, Inc. and Keystone Capital Advisors Announce Joint Venture to Help Small Business Owners Qualify for Capital
-
ETF Inflows Continue to Fuel the Technology Sector as QuantRate Launches AI Trading Bot to Help Investors Identify Institutional-Grade Market Signals
-
MUSSO Launches the AnyDesk D7: A Versatile, Foldable Home Office Workstation for the US
-
Extension of the terms of office of the Management Board members
-
Willis Lease Finance Corporation Acquires Three Airbus A330-300 Aircraft That Will Be Leased to China Airlines and EVA Air
-
Volantio Launches Vector, the Operating Platform of the Future for Modern Airlines
-
TransUnion Report Maps How Mortgage Rate Changes Could Reshape Local Housing Markets
-
Glass House Brands Announces Uplist to NYSE
-
Dynacor Board of Directors Elects Réjean Gourde as Chair; Board Positioned for Execution
-
Q2 Metals Commences Summer Drill Program and Advances Toward PEA on the Cisco Lithium Project in Quebec, Canada
-
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
-
SPIRIT BLOCKCHAIN CAPITAL COMPLETES SHARES FOR SERVICES ISSUANCE
-
NFI schedules second quarter 2026 financial results and conference call
-
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
-
VCI Global Strengthens Capital Alignment Following Premium Warrant Conversion by Institutional Investor
-
RenX Books Microtec Mill Shipment as Site Work Advances at Myakka City
-
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
-
Onex Partners and Co-Investors to Acquire AirSprint, Canada’s Leader in Fractional Jet Ownership
-
Intermap Expands Role in GPS-Denied Navigation with Third DOD Research Contract
-
Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer
-
Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel
-
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
-
Bombardier and Rolls-Royce Elevate Aircraft Health Monitoring for New and In-Service Global 5500 and 6500 Aircraft, Upgrade Now Available Across Bombardier’s Service Centre Network
-
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
-
New final terms for Euro Medium Term Note Programme - Nykredit Realkredit A/S
-
NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.
-
Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Trea
-
Storaktionærmeddelelse
-
Flash Sports & Media (Nasdaq: FLZH) Announces Planned Launch of Zimbabwe T20 League (ZT20)
-
Flash Sports & Media (Nasdaq: FLZH) Announces Planned Launch of Zimbabwe T20 League (ZT20)
-
Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026
-
Xali Gold Discovers Higher Grade Gold Mineralization at Pico Machay
-
Argo and Town of Caledon Announce Fall Smart Routing™ Launch
-
Impact Analytics Research Identifies Holiday 2026's Defining Promotional Strategy: Broader Reach, Disciplined Depth
-
Purpose Investments Inc. Announces Final June 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
NexGold Intersects 61.22 g/t Gold over 12.0 Metres and 5.85 g/t Gold over 13.0 Metres During Infill Drill Program at the Goldboro Gold Project in Nova Scotia
-
Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus
-
Asante Provides Strategic Review and Operational Update
-
Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis
-
Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
-
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
-
GDS Concludes Successful 2026 Annual General Meeting with All Resolutions Passed, Including Election and Re-election of Directors
